Parkinsons Disease - Pipeline Review, H1 Market Status, Opportunities, Market Forecasts Research Report: New Study

Market Survey On Parkinsons Disease - Pipeline Review, H1 2014: Research Background & Research Ideas

‘Parkinson's Disease - Pipeline Review, H1 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Parkinson's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Parkinson's Disease and special features on late-stage and discontinued projects.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/parkinsons-disease-pipeline-review-h1-2014

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/193846 

Scope

The report provides a snapshot of the global therapeutic landscape of Parkinson's Disease
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Parkinson's Disease and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Parkinson's Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Parkinson's Disease pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/193846 

Reasons to buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Parkinson's Disease
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Parkinson's Disease pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact 
M/s Sheela 
90 Sate Street, Suite 700 
Albany, NY 12207 
Tel: +1-518-618-1030 
USA – Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

New Study: Hemophilia Market Research Report: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Global Hemophilia Market Report: 2013 Edition

Hemophilia is a disorder in which the blood does not clot properly, leading to extended bleeding. The bleeding can be external or internal, especially in the knees, ankles, and elbows. There are two types of hemophilia: type A and type B. The market has been growing since past several years mainly due to improvement in technology, discovery of new coagulation factors, proteins, and plasma concentrates which are being used for treating chronic diseases and medical conditions.

To Read the Complete Report with TOC Visit:  http://www.marketresearchreports.biz/analysis-details/global-hemophilia-market-report-2013-edition

As more people suffer with Hemophilia A in comparison with Hemophilia B and Inhibitors, the Hemophilia A market is the largest in the world. The US accounts for the major population suffering with hemophilia globally.

The key trends observed within the market include inclination towards prophylaxis, long-acting factor VIII and IX development and growing penetration of rFVIII products in emerging markets which is a opportunity for manufacturers. On the development front, there has been an increase in the launch of new products by various companies. But there are certain challenges which the industry is facing as of now which include risk of antibody neutralization, emerging challenges for developing nations and rising cost of hemophilia treatment. The major factors which will contribute in the growth of the industry include rising male population, increasing expenditure on healthcare and increasing new patient registration.

The report studies the hemophilia market on a global scale and its various segments. The competition in the global hemophilia market is intense with few large players viz. Baxter, Grifols, Pfizer and Nova Noridisk. The competitive landscape along with the company profiles of the leading players in the market is discussed in detail.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/175545

TABLE OF CONTENT

1. Hemophilia: An Overview

Sign & Symptoms

Types of Hemophilia

Treatment

2. Market Overview

2.1 Global Hemophilia Market

Market Value

Patient Volume

2.2 Hemophilia Market by Segments

2.2.1 Hemophilia A

Market Value

Patient Volume

Key Products Comparison

FVIII Market

2.2.2 Hemophilia B

Market Value

Patient Volume

Key Products Comparison

FIX Market

2.2.3 Hemophilia with Inhibitor

Market Value

Patient Volume

Key Products

2.2.4 Von Willebrand Disease

2.3 Hemophilia Market by Region

2.3.1 Australia

2.3.2 The US

Market Value

Patient Volume

Market Segments

FVIII Market

FIX Market

For More Information Diseases & Conditions Market Research Reports @:

http://www.marketresearchreports.biz/category/67

3. Market Dynamics

3.1 Key Trends

3.1.1 Shift towards Prophylaxis

3.1.2 Long-Acting Factor VIII and IX Development

3.1.3 Rising Penetration of rFVIII Products in Emerging Markets

3.2 Growth Drivers

3.2.1 Rising Male Population

3.2.2 Increasing Expenditure on Healthcare

3.2.3 Increasing New Patient Registration

3.3 Significant Developments

3.3.1 Baxter Announced ADVATE Approval in China

3.3.2 Baxter Expands Access to Recombinant FVIII Hemophilia Treatment in Brazil

3.3.3 Novo Nordisk Files New Hemophilia Drug in EU, US

3.4 Challenges

3.4.1 Risk of Antibody Neutralization

3.4.2 Emerging Challenges for Developing Nations

3.4.3 Rising Cost of Hemophilia Treatment

4. Competitive Scenario

Market Share

Product Comparison

5. Company Profiles

5.1 Baxter International Inc.

5.1.1 Business Overview

5.1.2 Financial Overview

5.1.3 Business Strategies

Advancement of Core Portfolio

Expansion of Product Portfolio

5.2 Grifols

5.2.1 Business Overview

5.2.2 Financial Overview

5.2.3 Business Strategies

Expansion in Other Geographic Regions

Growth through Mergers & Acquisitions

5.3 Novo Nordisk

5.3.1 Business Description

5.3.2 Financial Highlights

5.3.3 Business Strategies

Product Innovation

5.4 Pfizer, Inc.

5.4.1 Business Overview

5.4.2 Financial Highlights

5.4.3 Business Strategies

Expansion in Emerging Markets

Growth through Acquisitions

About Us

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

With a team of experienced consultants we are committed to serve our clients in a way which increase their efficiency, reduce costs and saves time. Our professional search engine helps you in finding the best and latest market research report with just one click of the mouse. Our database represents the most updates and latest market research report collections form all the leading market research publishers across the globe

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://mrrfocuseconomics.blogspot.com/

Recent Market Report: Global Industry Inflammatory Bowel Disease Market Share 2013-2019

Inflammatory bowel disease (IBD) is an immune-mediated disease in which the body’s own immune system attacks the parts of the digestive system of the human body. Such disease involves inflammation of lower gastrointestinal tract and causes irreversible damage to the bowel. Ulcerative colitis and Crohn’s disease are the two major forms of IBD; both having distinct pathologic and clinical characteristics. IBD is a difficult to manage medical condition with a higher morbidity rate and thus its diagnosis and management is of utmost importance. 

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/inflammatory-bowel-disease-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

The global inflammatory bowel disease market is categorized as follows:

Application

• Therapeutic
• Diagnostic

Diseased condition

• Crohns disease
• Ulcerative colitis

Product type

• Aminosalicylates
• Antibiotics
• Corticosteroids
• Biologic therapies (biological drugs)
• Immunomodulators

Currently, the developed global markets of North America and Europe make up for the majority of the inflammatory bowel disease market in the world. Emerging markets of Asia mainly India, Russia and Japan as well as countries of Middle East and Latin America are also expected to show strong growth due to rising incidences of such diseases owing to increased industrialization, modernization of the population and drastic lifestyle changes.

One of the key factors driving the growth of this market is the increase in use of biological therapies such as monoclonal antibodies. However, difficulties involved in affording the expensive treatments of such diseases may pose challenge to growth of inflammatory bowel diseases market majorly in developing nations.

Some of the key players in this industry are Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb Company, Alcon, Inc., Baxter International, Inc., Johnson & Johnson, Sequella, Inc., Sanofi-Aventis LLC, Osiris Therapeutics, Inc., AstraZeneca PLC, Eisai Co. Ltd., Cephalon, Inc., Celltrion, Inc., Pfizer, Inc., Pluristem Therapeutics, Inc., Soligenix, Inc. and Ore Pharmaceuticals, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/172858

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

  

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Market Research Report: Global Parkinson\'s Disease Market Size 2012-2016: Market Research Report

Description

TechNavio's analysts forecast the Global Parkinson's Disease market to grow at a CAGR of 1.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the aging population. The Global Parkinson’s Disease market has also been witnessing the transition toward using drugs that have new mechanisms of action. However, weak pipeline landscape could pose a challenge to the growth of this market.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/global-parkinsons-disease-market-2012-2016

TechNavio's report, the Global Parkinson's Disease Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Parkinson's Disease market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include GlaxoSmithKline plc, Novartis AG, Orion Corp., and Teva Pharmaceuticals Industries Ltd.

The other vendors mentioned in the report are AbbVie Inc., Acadia Pharmaceuticals Inc., Avicena Group Inc., BoehringerIngelheim GmbH, Impax Laboratories Inc., Lundbeck A/S, Newron Pharmaceuticals SpA, Solvay Pharmaceuticals Inc., and Valeant International SRL.

Key questions answered in this report:

• What will the market size be in 2016 and what will be the growth rate?
• What are key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by key vendors?
• What are the strengths and weaknesses of each of these key vendors?

To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172661         

TABLE OF CONTENT

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

Market Research Process

Research Design

Research Methodology

5. Scope of the Report

Market Overview

Product Offerings

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/